Company
Amplo Biotechnology
http://amplobiotechnology.com/
| Industry | biotech company dedicated to developing innovative AAV-based gene therapies for neuromuscular junction disorders, announced the award of a Fast Track Phase I/II STTR grant from the NIH-NIAMS |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Amplo Biotechnology | Fast Track Phase I/II STTR Grant from NIH-NIAMS | 2023-05-29 |